AnnJi Pharma Reports Positive Phase 1/2a results for AJ20
21 May 2025 //
PR NEWSWIRE
AnnJi Pharma inks deal worth $250 M for muscular atrophy treatment
14 Mar 2023 //
BIOSPECTRUM ASIA
AnnJi Pharmaceutical Announced A Licensing Agreement With Avenue Therapeutics
10 Mar 2023 //
PR NEWSWIRE